Patents Justia - Marvin Edeas

Patents Justia - Marvin Edeas

Marvin Edeas - Visiting Professor at the Cochin Institute

Marvin Edeas ( holds studies in nephrology patients and studies the impact of microbiota metabolites on mitochondrial activity of such patients. He got to be a member of the team that is working with inflammation, cell proliferation and oxidative stress. Attracting in excess of 400 individuals, Marvin Edeas chaired the Scientific Committee at the Targeting Microbiota and Mitochondria Congress of 2016. His research and study concentrates on the effects of Inflammation and Oxidative Stress in chronic diseases.

Marvin Edeas - Oysters and Peptides Derived from Hydrolysates Modulate Oxidative Stress

Very real uses have been discovered for the developments made by Marvin Edeas. His patents had to do with the use of an oyster enzyme hydrolyzate within a composition that eliminates free radicals and modulates oxidative stress. In the US and Europe, Marvin Edeas has filed two patents.

Important Research on HIV

The factors which lead to blastogenic plasma in HIV Type 1 cases were revealed by Marvin Edeas in 1997. Back in the nineties, he carried out significant studies on the acquired immunodeficiency virus. He was a participant in the earliest clinical study that looked at the impact of antiretroviral therapy on hyperlactatemia and lactic acidosis. Marvin Edeas was rewarded by Sidaction for his efforts on HIV.

His annual congress, Paris Redox, is quite logically taken control of by the Chair of the International Society of Antioxidants (ISANH). Marvin Edeas associates with the Agency for the Evaluation of Research and Higher-Education (AERES) and the National Science Center in Krakow, Poland. Marvin Edeas chairs the global conference Targeting Microbiota and Mitochondria.

Autres Sujets